top of page

RJW&partners_Logo_NAVY_exclusion.png

Our latest thinking, insights and company news

CONTACT US TODAY

Never miss an update, subscribe today.

RJW&partners will only use your personal information to administer your account and provide the products and services you request. You can unsubscribe at any time, to do so please review our Privacy Policy. By clicking subscribe, you consent to allow RJW&partners to store and process your personal information.

NICE Scientific Advice – an updated process from 1st December 2022

Dec 5, 2022
1 min

NICE Scientific Advice – an updated process from 1st December 2022

NICE updated the process for providing scientific advice on December 2022, We describe these changes.

104 views

The Emergence of HTA in the Middle East and North Africa Region

Oct 31, 2022
13 min

The Emergence of HTA in the Middle East and North Africa Region

As more stakeholders from the healthcare sector embrace evidence-based policy development and decision-making, we take a look at the latest

45 views

Will US payers cope with the influx of high-cost cell and gene therapies over the coming years?

Apr 13, 2022
9 min

Will US payers cope with the influx of high-cost cell and gene therapies over the coming years?

A summary of some of the challenges and solutions associated with cell and gene therapy coverage and pricing in the US

173 views

Is it business as usual for Pharma in Russia?

Mar 23, 2022
2 min

Is it business as usual for Pharma in Russia?

A summary of the impact of Russia invasion of Ukraine on the biopharmaceutical industry so far

89 views

Mar 22, 2022
14 min

Rare diseases are not that rare after all...

What are the key drivers of willingness to pay for Orphan Medical Products (OMPs) in the UK, France, Germany, Italy & Spain?

48 views

Helen Johnson joins RJW&partners as Director

Jan 6, 2022
2 min

Helen Johnson joins RJW&partners as Director

We are delighted to announce the appointment of Helen Johnson as Director.

269 views

bottom of page